Diane

Diane V. Havlir, MD Chief, HIV/AIDS Division, SFGH UCSF Principal Investigator, MU-UCSF Collaboration Affiliation: MU-UCSF E-mail Address: dhavlir@php.ucsf.edu Professional Interests: HIV therapeutic strategies HIV and co-infections (TB and Malaria)
Current Main Activities: Research: Strategies to address the intersection of HIV, TB, Malaria in Subsarahan Africa. Service: Chair, TB/HIV Working Group of the Stop TB Partnership International AIDS Society (IAS) Governing Council WHO Committee on Antiretroviral Guidelines for Resource Limited Settings Teaching: Mentoring U.S. and Ugandan junior investigators in patient based and translational research. Key Publications: Havlir, D. V. and P. F. Barnes (1999). "Tuberculosis in patients with human immunodeficiency virus infection." N Engl J Med 340(5): 367-73. Havlir, D.V., R. Bassett, D. Levitan, P. Gilbert, P. Tebas, A.C. Collier, M.S. Hirsch, C. Ignacio, J. Condra, H.F. Gunthard, D.D. Richman, and J.K. Wong, Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA, 2001. 286(2): p. 171-9. Havlir, D.V., M.C. Strain, M. Clerici, C. Ignacio, D. Trabattoni, P. Ferrante, and J.K. Wong, Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol, 2003. 77(20): p. 11212-9. Havlir, D.V. and S.M. Hammer, Patents versus patients? Antiretroviral therapy in India. N Engl J Med, 2005. 353(8): p. 749-51. Huang, L., A. Quartin, D. Jones, and D.V. Havlir, Intensive care of patients with HIV infection. N Engl J Med, 2006. 355(2): p. 173-81. Kamya, M.R., A.F. Gasasira, A. Yeka, N. Bakyaita, S.L. Nsobya, D. Francis, P.J. Rosenthal, G. Dorsey, and D. Havlir, Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis, 2006. 193(1): p. 9-15. Luetkemeyer, A. F., E. D. Charlebois, L. L. Flores, D. R. Bangsberg, S. G. Deeks, J. N. Martin and D. V. Havlir (2007). "Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals." Am J Respir Crit Care Med 175(7): 737-42. Education and Training: BA, St. Olaf College, Northfield, Minnesota, 1980 MD, Duke University Medical School, Durham, North Carolina, 1984 Categorical Internal Medicine Residency, University of California, San Francisco, 1984-1987 Fellowship, Infectious Diseases, Case Western Reserve University, Cleveland, Ohio, 1988-1990

Diane V. Havlir, MD

Chief, HIV/AIDS Division, SFGH UCSF
Principal Investigator, MU-UCSF Collaboration

Affiliation: MU-UCSF

E-mail Address: dhavlir@php.ucsf.edu

Professional Interests:
HIV therapeutic strategies HIV and co-infections (TB and Malaria)

Current Main Activities:
Research: Strategies to address the intersection of HIV, TB, Malaria in Subsarahan Africa.
Service: Chair, TB/HIV Working Group of the Stop TB Partnership International AIDS Society (IAS) Governing Council WHO Committee on Antiretroviral Guidelines for Resource Limited Settings
Teaching: Mentoring U.S. and Ugandan junior investigators in patient based and translational research.

Key Publications:

Havlir, D. V. and P. F. Barnes (1999). "Tuberculosis in patients with human immunodeficiency virus infection." N Engl J Med 340(5): 367-73.

Havlir, D.V., R. Bassett, D. Levitan, P. Gilbert, P. Tebas, A.C. Collier, M.S. Hirsch, C. Ignacio, J. Condra, H.F. Gunthard, D.D. Richman, and J.K. Wong, Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA, 2001. 286(2): p. 171-9.

Havlir, D.V., M.C. Strain, M. Clerici, C. Ignacio, D. Trabattoni, P. Ferrante, and J.K. Wong, Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol, 2003. 77(20): p. 11212-9.

Havlir, D.V. and S.M. Hammer, Patents versus patients? Antiretroviral therapy in India. N Engl J Med, 2005. 353(8): p. 749-51.

Huang, L., A. Quartin, D. Jones, and D.V. Havlir, Intensive care of patients with HIV infection. N Engl J Med, 2006. 355(2): p. 173-81.

Kamya, M.R., A.F. Gasasira, A. Yeka, N. Bakyaita, S.L. Nsobya, D. Francis, P.J. Rosenthal, G. Dorsey, and D. Havlir, Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis, 2006. 193(1): p. 9-15.

Luetkemeyer, A. F., E. D. Charlebois, L. L. Flores, D. R. Bangsberg, S. G. Deeks, J. N. Martin and D. V. Havlir (2007). "Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals." Am J Respir Crit Care Med 175(7): 737-42.

Education and Training:
BA, St. Olaf College, Northfield, Minnesota, 1980
MD, Duke University Medical School, Durham, North Carolina, 1984
Categorical Internal Medicine Residency, University of California, San Francisco, 1984-1987
Fellowship, Infectious Diseases, Case Western Reserve University, Cleveland, Ohio, 1988-1990

MU-UCSF Research Collaboration